אסטרומייט וטרינרי ישראל - עברית - Ministry of Health

אסטרומייט וטרינרי

intervet ( israel) ltd - cloprostenol as sodium 263 mcg/ml - solution for injection - estrumate is a potent luteolytic agent. it causes functional and morphological regression of the corpus luteum ( luteolysis) in cattle and horses followed by return to oestrus and normal ovulation.

בייאטה 5 מק"ג ישראל - עברית - Ministry of Health

בייאטה 5 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

בייאטה 5 מק"ג ישראל - עברית - Ministry of Health

בייאטה 5 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

בייאטה 10 מק"ג ישראל - עברית - Ministry of Health

בייאטה 10 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

בייאטה 10 מק"ג ישראל - עברית - Ministry of Health

בייאטה 10 מק"ג

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

סודיום כלוריד % 0.9 ישראל - עברית - Ministry of Health

סודיום כלוריד % 0.9

lapidot medical import and marketing ltd - sodium chloride 0.9 g / 100 ml - solution for injection - sodium chloride - plasma isotonic fluid repacement. vehicle solution for supplementary medication fluid and electrolyte replacement ,hypochloremic alkalosis and chloride losses, externally for wound irrigation and moistening of wound dressings,

סודיום כלוריד % 0.9 טבע ® ישראל - עברית - Ministry of Health

סודיום כלוריד % 0.9 טבע ®

teva medical marketing ltd. - sodium chloride 9 mg/ml - solution for infusion - sodium chloride - a source of water and electrolytes. also indicated for use as a priming solution in hemodialysis procedures.

לקטט רינגר להזרקה ישראל - עברית - Ministry of Health

לקטט רינגר להזרקה

neopharm (israel) 1996 ltd - calcium chloride 27 mg / 100 ml; lactic acid as sodium 0.533 g / 100 ml - solution for injection - combinations of electrolytes - isotonic injectable solution.

ניאו- מדרול תחליב אקנה ישראל - עברית - Ministry of Health

ניאו- מדרול תחליב אקנה

pfizer pfe pharmaceuticals israel ltd - aluminium chlorohydroxide complex solution; methylprednisolone acetate; neomycin sulfate; sulfur - תרחיץ - methylprednisolone acetate 2.5 mg/ml; neomycin sulfate 2.5 mg/ml; sulfur 50 mg/ml; aluminium chlorohydroxide complex solution 200 mg/ml - methylprednisolone - methylprednisolone - acne.

מתוטרקסאט "אבווה" 10 מ"ג/מ"ל ישראל - עברית - Ministry of Health

מתוטרקסאט "אבווה" 10 מ"ג/מ"ל

pharmalogic ltd - methotrexate 10 mg/ml - solution for injection - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. methotrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, methotrexate is indicated only in the